Click image to enlarge
The V-PLEX SARS-CoV-2 Panel 38 (ACE2) Kit is a multiplex assay for antibodies that block the binding of ACE2 to the Spike antigens from the SARS-CoV-2 virus, including several sublineages of the Omicron variant currently in circulation. Panel 38 includes: SARS-CoV-2 N, SARS-CoV-2 Spike, SARS-CoV-2 Spike (BA.2.86), SARS-CoV-2 Spike (BA.5), SARS-CoV-2 Spike (EG.5.1), SARS-CoV-2 Spike (FL.1.5.1), SARS-CoV-2 Spike (HV.1), SARS-CoV-2 Spike (JD.1.1), SARS-CoV-2 Spike (JN.1), and SARS-CoV-2 Spike (XBB.1.5).
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
Analyte(s)
|
|
SARS-CoV-2 N, SARS-CoV-2 Spike, SARS-CoV-2 Spike (BA.2.86), SARS-CoV-2 Spike (BA.5), SARS-CoV-2 Spike (EG.5.1), SARS-CoV-2 Spike (FL.1.5.1), SARS-CoV-2 Spike (HV.1), SARS-CoV-2 Spike (JD.1.1), SARS-CoV-2 Spike (JN.1), SARS-CoV-2 Spike (XBB.1.5)
|
|
Species
|
|
Human
|
|
Instrument(s)
|
|
MESO QuickPlex SQ 120
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO SECTOR S 600MM
|
|
Plate Type
|
|
96-well
|
|
Sample Type
|
|
Serum, Plasma
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
≤-70 °C
|
1 vial (1 vial)
|
|
|
2-8 °C
|
1 vial (5 plate size)
|
|
SARS-CoV-2 Plate 38
|
2-8 °C
|
5 each (1 each)
|
|
|
2-8 °C
|
1 bottle (200 mL)
|
|
|
RT
|
1 bottle (90 mL)
|
|
|
RT
|
1 bottle (100 mL)
|
|
MSD Blocker A
|
RT
|
1 bottle (250 mL)
|
|
MSD Phosphate Buffer 5X
|
RT
|
1 bottle (50 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
≤-70 °C
|
5 vial (1 vial)
|
|
|
2-8 °C
|
5 vial (5 plate size)
|
|
SARS-CoV-2 Plate 38
|
2-8 °C
|
25 each (1 each)
|
|
|
2-8 °C
|
5 bottle (200 mL)
|
|
|
RT
|
5 bottle (90 mL)
|
|
|
RT
|
5 bottle (100 mL)
|
|
MSD Blocker A
|
RT
|
5 bottle (250 mL)
|
|
MSD Phosphate Buffer 5X
|
RT
|
5 bottle (50 mL)
|
|
Product Inserts
|
|
|
Certificate of analysis
|
|
|
Handouts
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay
|
|
|
|
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
|
|
|
|
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
|
|
|
|
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination
|
|
|
|
SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters